AYA
ARTRYA FPO [AYA]
Healthcare · ASX Small Cap
$3.3900 +8.6%
Updated 26 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +12First seen: 2026-02-25
Score Breakdown
Technical79
Catalyst50
Sentiment50
Fundamental82
Momentum72
Risk Gate50
Get alerts when AYA's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD just crossed bullish — momentum is shifting to the upside
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- On a tear — up 26.5% over the last 5 days
- Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (15 quarters)
- Very high P/S ratio (16504.5x)
- Moderate revenue growth (+8%)
- EPS estimates revised upward (+10pts)
- CANSLIM I: Institutional ownership (33%)
- Sentiment is mixed — no strong consensus either way
- Strong long-term momentum — up 347% over the past year (excluding last month)
- Excellent risk-adjusted returns — Sharpe of 2.4 means strong gains without wild swings
- RBA hiking (-3pts)
- Calendar: Clinical Trial in 7d (+5pts)
Risk Signals
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.60%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about AYA
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Change of Company Secretary
NONE Update - S&P DJI March 2026 Rebalance of the All Ordinaries
NONE Notification of cessation of securities - AYA
Recent ASX Announcements
| 2026-03-17 | Change of Company Secretary |
| 2026-03-10 | Update - S&P DJI March 2026 Rebalance of the All Ordinaries PRICE SENSITIVE |
| 2026-03-09 | Notification of cessation of securities - AYA |
| 2026-03-08 | Company Presentation |
| 2026-03-06 | S&P DJI Announces March 2026 Quarterly Rebalance PRICE SENSITIVE |
Key Metrics
$478.6M
Market Cap
451K
Avg Volume
1.1x
Vol Ratio
$0.56 — $5.24
52-Week Range
0.8%
Short Interest
N/A
Cash Runway
-37.9%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 67% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | pass | Inst: 33% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #10 of 117 · Sector avg: 46
View all Healthcare signals →Track AYA and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required